Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease

BACKGROUND: Heart failure with reduced ejection fraction (HFrEF) is a chronic disease with substantial mortality. Management of HFrEF has seen significant breakthrough after the launch of neprilysin inhibitor. The PARADIGM‐HF (Prospective Comparison of ARNI with ACEI to Determine Impacton Global Mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Chih‐Yuan, Yang, Shang‐Feng, Ou, Shuo‐Ming, Wu, Cheng‐Hsueh, Huang, Po‐Hsun, Hung, Chung‐Lieh, Lin, Chih‐Ching, Li, Szu‐Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683670/
https://www.ncbi.nlm.nih.gov/pubmed/36062622
http://dx.doi.org/10.1161/JAHA.122.026407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683670/
https://www.ncbi.nlm.nih.gov/pubmed/36062622
http://dx.doi.org/10.1161/JAHA.122.026407

Ejemplares similares